===== "This is a very declarative statement and the first one from Dor in a PR that highlights the data with a guarantee period."
I don't think that statement came from Dor. It came from the Expert Opinions report and was written by George B. McDonald.
A few interesting facts:
===========================================================
The publication "Oral Beclomethasone Dipropionate, a Topically-Active Corticosteroid for Treatment of Gastrointestinal Graft-vs.-Host-Disease Following Allogeneic Hematopoietic Cell Transplantation," is authored by George B. McDonald, MD, inventor of orBec® and Head of the Gastroenterology/Hepatology Section at the Fred Hutchinson Cancer Research Center, located in Seattle, Washington.
===========================================================
msg #812
===========================================================
The second trial was a 60-patient Phase 2 single-center clinical trial conducted at the Fred Hutchinson Cancer Research Center. ===========================================================
msg #812
===========================================================
G McDonald is a consultant to DOR BioPharma, Inc. and has an equity position with the company.
===========================================================
From the full text
Now let me get this straight.
1) George McDonald is the inventor of orBec
2) George McDonald is the Head of the Gastroenterology/Hepatology Section at the Fred Hutchinson Cancer Research Center
3) The PII study was conducted in its entirety at the Fred Hutchinson Cancer Research Center
4) George McDonald is a consultant to DOR BioPharma, Inc.
5) George McDonald has an equity position in DOR
After considering the above, I find it truly SHOCKING that he would believe that the orBec data/case is conclusive.
And some posters complain about Conflicts of Interest at the FDA. Priceless! :)
NoBuddy
